Food and drug manufacturers’ inspection records and citations for misleading advertising will be disclosed by U.S. regulators as part of the Obama administration’s efforts to improve transparency in government.
FDA to widen compliance disclosure
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You